ArticleNature communications2026

A lipoprotein-biomimetic nanoplatform for oncogenic KRAS mutation-specific lysosome-targeting protein degradation.

Hang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.